LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
48.69 0.00   0.00%3.47%1,1231.4M

Market data is delayed by at least 20 minutes.
Previous close 1/14/2013
 
 
 

Latest News Headlines for Sanofi SA

NBA Family, American Diabetes Association, and Sanofi US Tip Off 2013 Dribble To Stop Diabetes Awareness Campaign
1 days 4 minutes ago - Pr Newswire
The National Basketball Association (NBA), the Women's National Basketball Association (WNBA), and the NBA Development League, in collaboration with the American Diabetes Association and Sanofi US, today announced the tip-off of the 2013 Dribble to Stop Diabetes initiative, a national campaign designed to encourage fans to live an active, healthy lifestyle and raise awareness about type 2 diabetes prevention and management, along with the potentially serious health complications that can be associated with the disease.
Relatively Good Performance Detected in Shares of Forest Laboratories in the Pharmaceuticals Industry (FRX, MRK, SNY, MDCO, SLXP)
1 days 5 minutes ago - Financial News Network Online - News Corner
Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming. This is what we found:
Watch for Continued Gains in Shares of Sanofi-Aventis (SNY)
3 days 16 hours 58 minutes ago - Financial News Netwfork Online - 52-Week High-Lows
Sanofi-Aventis (NYSE:SNY) traded today at a new 52-week high of $49.28. So far today approximately 801,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Over the past year, Sanofi-Aventis has traded in a range of $33.03 to $49.28 and is now at $49.01, 48% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 0.8%.
View more recent headlines
 
 
 
Company Background
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. As of January 31, 2012, the Company's major shareholder was L'oreal with a stake of 8.82%.

Bid/Size
-- / --
Ask/Size
-- / --
Price Open
0.00
Previous Close
48.69
Day High
0.00
Day Low
0.00
52wk High/Date
49.28 / 1/11/2013
52wk Low/Date
33.03 / 6/1/2012
% off 52wk High
-1.20%
% off 52wk Low
47.41%
Beta (5 Yr)
0.9
Market Capitalization
128.3B
Shares Outstanding
2.6B
Volatility Avg
33.50
EPS(TTM)
3.03
P/E Ratio
16.1x
Dividend Announcement
2/9/2012
Yield
3.47%
Ex-Date
5/7/2012
Date of Record
5/9/2012
Payable
1.6892 - ANN
Payable Date
5/30/2012
Last Trade as of 1/14/2013 4:03 PM ET
 
 
 

SNY Sanofi SA vs. Peers

Peers 
SNY
Sanofi SA
2.76%
Abbott Laboratories
6.45%
Bristol Myers Squibb Co.
5.00%
Eli Lilly & Co.
7.06%
Merck & Co., Inc.
5.86%
SNY
Sanofi SA
3.47%
Abbott Laboratories
1.68%
Bristol Myers Squibb Co.
4.09%
Eli Lilly & Co.
3.71%
Merck & Co., Inc.
3.97%
SNY
Sanofi SA
0.00%
Abbott Laboratories
0.00%
Bristol Myers Squibb Co.
0.00%
Eli Lilly & Co.
0.00%
Merck & Co., Inc.
0.00%
Compare these stocks